KMTS Kestra Medical Technologies, Ltd.

Fundamentals / CIK 0001877184 / USD

Kestra Medical Technologies, Ltd. reported $106.7M in revenue and a net loss of $149.9M for the trailing twelve months ended July 31, 2026 (up 59.9% year over year), with a 53.9% gross margin and a -134.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KMTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2024 to 2026), reported in USD.

$107.7M$53.83M$0-$131.1MFY 2024 Revenue: $27.81MFY 2024 Net Income: -$94.12M2024FY 2025 Revenue: $59.81MFY 2025 Net Income: -$113.8M2025FY 2026 Revenue: $95.13MFY 2026 Net Income: -$131.6M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Apr 30 Apr 30 Apr 30
Revenue $95.13M $59.81M $27.81M
Cost of Revenue $46.26M $35.60M $27.45M
Gross Profit $48.86M $24.21M $362K
Research & Development $19.48M $15.65M $15.49M
Selling, General & Admin $164.1M $114.9M $69.94M
Total Operating Expenses $183.6M $130.6M $85.42M
Operating Income -$134.7M -$106.4M -$85.06M
EBITDA -$126.0M -$98.41M -$73.50M
Interest Income $8.35M $3.20M --
Interest Expense $7.55M $7.73M $6.23M
Income Before Tax -$131.3M -$113.7M -$94.10M
Income Tax Expense $294K $135K $24K
Net Income -$131.6M -$113.8M -$94.12M
Basic EPS -$2.43 -$5.13 -$5.07
Diluted EPS -$2.43 -$5.13 -$5.07
Basic Shares Outstanding 54.2M 24.6M 19.9M
Diluted Shares Outstanding 54.2M 24.6M 19.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue $30.97M $28.64M $24.55M $22.57M $19.37M $17.23M $15.09M $14.71M
Cost of Revenue $13.47M $12.96M $11.65M $11.14M $10.52M $9.60M $8.54M $8.88M
Gross Profit $17.50M $15.68M $12.91M $11.42M $8.85M $7.63M $6.55M $5.83M
Research & Development $6.80M $5.63M $4.97M $4.88M $4.00M $5.39M $3.35M $3.51M
Selling, General & Admin $48.36M $49.39M $42.70M $38.30M $33.73M $50.46M $23.80M $21.45M
Total Operating Expenses $55.16M $55.03M $47.67M $43.18M $37.73M $55.84M $27.15M $24.96M
Operating Income -$37.66M -$39.34M -$34.77M -$31.75M -$28.88M -$48.21M -$20.60M -$19.13M
EBITDA -$34.99M -$37.02M -$32.78M -$29.38M -$26.85M -$46.38M -$18.71M -$17.27M
Interest Income $2.12M $2.23M $2.16M $1.80M $2.17M $1.66M $628K $878K
Interest Expense $1.93M $1.84M $1.89M $1.90M $1.91M $1.76M $1.78M $2.32M
Income Before Tax -$44.04M -$38.64M -$34.13M -$32.75M -$25.79M -$51.01M -$21.74M -$20.61M
Income Tax Expense $50K $192K $35K $34K $33K $102K $18K $8.0K
Net Income -$44.09M -$38.84M -$34.17M -$32.78M -$25.83M -$52.05M -$21.51M -$20.37M
Basic EPS -$0.75 -- -$0.61 -$0.64 -$0.50 -- -$1.25 -$1.19
Diluted EPS -$0.75 -- -$0.61 -$0.64 -$0.50 -- -$1.25 -$1.19
Basic Shares Outstanding 58.6M -- 55.8M 51.4M 51.3M -- 19.9M 19.9M
Diluted Shares Outstanding 58.6M -- 55.8M 51.4M 51.3M -- 19.9M 19.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Apr 30 Apr 30 Apr 30
Cash & Cash Equivalents $99.71M $237.6M $8.25M
Short-Term Investments $96.72M -- --
Cash & Short-Term Investments $262.2M $237.6M $8.25M
Accounts Receivable, Net $14.54M $8.08M $2.00M
Other Current Assets $2.98M $1.69M $419K
Total Current Assets $222.4M $255.3M $14.91M
Property, Plant & Equipment, Net $59.09M $34.83M $26.11M
Long-Term Investments $65.77M -- --
Other Non-Current Assets $5.79M $1.15M $607K
Total Non-Current Assets $136.1M $40.42M $31.04M
Total Assets $358.5M $295.7M $45.95M
Accounts Payable $27.30M $23.96M $23.89M
Total Current Liabilities $50.37M $37.98M $32.97M
Long-Term Debt $42.65M $41.10M $42.54M
Other Non-Current Liabilities $306K $140K $76K
Total Non-Current Liabilities $48.44M $52.36M $45.24M
Total Liabilities $98.81M $90.34M $78.22M
Total Debt (incl. Leases) $46.79M $44.31M $45.17M
Common Stock $58.38M $51.35M $19.91M
Retained Earnings -$651.9M -$520.2M -$406.4M
Accumulated Other Comp. Income -$218K -- --
Total Equity $259.7M $205.4M -$209.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2024-04-30
Cash & Cash Equivalents $68.56M $99.71M $291.3M $175.4M $201.2M $237.6M $8.25M
Short-Term Investments $130.4M $96.72M -- -- -- -- --
Cash & Short-Term Investments $244.7M $262.2M $291.3M $175.4M $201.2M $237.6M $8.25M
Accounts Receivable, Net $15.41M $14.54M $12.71M $10.41M $9.25M $8.08M $2.00M
Other Current Assets $2.12M $2.98M $1.49M $1.35M $1.62M $1.69M $419K
Total Current Assets $226.3M $222.4M $314.1M $195.4M $220.7M $255.3M $14.91M
Property, Plant & Equipment, Net $63.66M $59.09M $53.80M $45.93M $40.38M $34.83M $26.11M
Long-Term Investments $45.79M $65.77M -- -- -- -- --
Other Non-Current Assets $6.20M $5.79M $5.88M $1.20M $1.06M $1.15M $607K
Total Non-Current Assets $121.1M $136.1M $65.28M $51.29M $45.60M $40.42M $31.04M
Total Assets $347.4M $358.5M $379.3M $246.7M $266.3M $295.7M $45.95M
Accounts Payable $25.96M $27.30M $24.02M $20.21M $18.57M $23.96M $23.89M
Total Current Liabilities $48.27M $50.37M $42.93M $35.76M $32.26M $37.98M $32.97M
Long-Term Debt $72.50M $42.65M $42.26M $41.87M $41.49M $41.10M $42.54M
Other Non-Current Liabilities $306K $306K $140K $140K $140K $140K $76K
Total Non-Current Liabilities $76.73M $48.44M $48.42M $46.86M $49.88M $52.36M $45.24M
Total Liabilities $125.0M $98.81M $91.35M $82.62M $82.14M $90.34M $78.22M
Total Debt (incl. Leases) $76.45M $46.79M $46.55M $44.80M $44.59M $44.31M $45.17M
Common Stock $59.27M $58.38M $58.35M $51.45M $51.35M $51.35M $19.91M
Retained Earnings -$695.9M -$651.9M -$613.0M -$578.9M -$546.1M -$520.2M -$406.4M
Accumulated Other Comp. Income -$471K -$218K -- -- -- -- --
Total Equity $222.4M $259.7M $288.0M $164.1M $184.2M $205.4M -$209.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Apr 30 Apr 30 Apr 30
Net Income -$131.6M -$113.8M -$94.12M
Depreciation & Amortization $8.71M $7.97M $11.56M
Stock-Based Compensation $33.64M $24.27M $1.49M
Change in Receivables -$9.06M -$8.78M -$2.50M
Change in Payables $4.30M $2.84M $7.34M
Operating Cash Flow -$81.70M -$77.61M -$72.23M
Capital Expenditure -$34.89M -$22.94M -$12.23M
Free Cash Flow -$116.6M -$100.5M -$84.46M
Purchases of Investments -$163.0M -- --
Investing Cash Flow -$203.3M -$23.31M -$12.23M
Common Stock Issued $149.3M $215.8M --
Financing Cash Flow $147.1M $330.3M $77.72M
Net Change in Cash -$137.9M $229.3M -$6.74M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$44.09M -$38.84M -$34.17M -$32.78M -$25.83M -$51.11M -$21.76M -$20.62M
Depreciation & Amortization $2.66M $2.33M $1.98M $2.37M $2.03M $1.84M $1.89M $1.87M
Stock-Based Compensation $9.52M $10.30M $10.11M $8.65M $4.58M $22.31M $459K $1.12M
Change in Receivables -$48K -$2.91M -$2.66M -$1.71M -$1.78M -$963K -$3.34M -$1.58M
Change in Payables -$1.88M $4.95M $1.73M $524K -$2.90M -$823K $4.01M -$2.61M
Operating Cash Flow -$32.30M -$18.72M -$18.37M -$18.34M -$26.27M -$24.06M -$18.00M -$18.06M
Capital Expenditure -$8.34M -$9.66M -$9.80M -$7.26M -$8.17M -$7.39M -$4.06M -$4.45M
Free Cash Flow -$40.63M -$28.38M -$28.16M -$25.61M -$34.44M -$31.45M -$22.06M -$22.50M
Purchases of Investments -$13.02M -- -- -- -- -- -- --
Investing Cash Flow -$21.35M -$172.7M -$14.92M -$7.42M -$8.23M -$7.40M -$4.45M -$4.42M
Financing Cash Flow $22.50M -$185K $149.2M -$27K -$1.88M $214.7M -$119K -$575K
Net Change in Cash -$31.15M -$191.6M $115.9M -$25.79M -$36.38M $183.2M -$22.57M -$23.05M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Apr 30 Apr 30 Apr 30
Gross Margin 51.4% 40.5% 1.3%
Operating Margin -141.6% -177.8% -305.8%
Net Profit Margin -138.4% -190.3% -338.4%
Return on Assets (ROA) -36.7% -38.5% -204.8%
Current Ratio 4.41x 6.72x 0.45x
Quick Ratio 5.49x 6.47x 0.31x
Revenue Growth (YoY) +59.0% +115.1% --
Gross Profit Growth (YoY) +101.8% +6587.8% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Gross Margin 53.9% 51.4% 48.8% 46.4% 43.5% 40.5% -- --
Operating Margin -134.5% -141.6% -171.5% -174.3% -175.9% -177.8% -- --
Net Profit Margin -140.4% -138.4% -173.0% -178.0% -180.3% -190.3% -- --
Return on Assets (ROA) -43.1% -36.7% -38.2% -53.6% -45.0% -38.5% -- --
Current Ratio 4.69x 4.41x 7.32x 5.47x 6.84x 6.72x -- --
Quick Ratio 5.39x 5.49x 7.08x 5.20x 6.52x 6.47x -- --
Revenue Growth (YoY) +59.9% +66.2% +62.7% +53.4% +51.5% -- -- --
Gross Profit Growth (YoY) +97.7% +105.5% +97.1% +96.0% +110.7% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001877184) · from April 30, 2024 Data through July 31, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal